My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
January 2015
Obama Requests Doubling of Funds to Combat Antibiotic Resistance
President Obama’s budget request for fiscal year 2016 devotes significant new resources to combat antimicrobial resistance. The request doubles current federal funds dedicated to drug resistance to over $1.2 billion and would address key recommendations from the 2014 President’s Council of Advisors on Science and Technology (PCAST) Report to the President on Combating Antibiotic Resistance.

Specifically, the president’s budget would revitalize the pipelines for new antibiotics and diagnostics, with over $650 million to the National Institutes of Health (NIH) and Biomedical Advanced Research and Development Authority (BARDA) to jumpstart research and development through increased partnerships with academia and industry. Further, it would provide long overdue investments in the Centers for Disease Control and Prevention (CDC) and other agencies to strengthen antibiotic use and resistance surveillance in humans and food-producing animals. The president’s budget also reflects the need for appropriate stewardship of existing antibiotics as a strategy to preserve their utility.

IDSA strongly supports the president’s proposal and will continue to advocate for the passage of important legislation, such as the Promise for Antibiotics and Therapeutics for Health (PATH) Act, and the Antibiotic Development to Advance Patient Treatment (ADAPT) Act, to speed patient access to the most desperately needed antibiotics, and tax credits to spur antibiotic and diagnostic research and development.

You can support IDSA’s antimicrobial resistance funding advocacy efforts by taking three minutes to sign on to our Action Alert.

In a separate statement, HIVMA expressed support for the continued, and in some instances, increased funding for HIV/AIDS domestically. The budget proposal includes an increase in NIH funding by $1.2 billion as well as increases at the CDC of $31.5 million for viral hepatitis and $12.6 million for domestic HIV prevention. The president would consolidate Ryan White Part D into Ryan White Part C and would increase funding for the consolidated programs by $4 million. Other Parts of the Ryan White HIV/AIDS program would be flat funded.

Unfortunately, proposed funding for global health issues is disappointing. The president’s budget would flat-fund the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and would cut spending on global tuberculosis response. In a statement, IDSA’s Center for Global Health Policy urged Congress to fund these programs at higher levels.

IDSA and HIVMA staff will continue to examine the budget for potential impacts on initiatives important to antimicrobial resistance and infectious diseases including HIV/AIDS both domestically and internationally.

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:

New Resources Available for Accessing Guidelines
Sanford Guide Mobile App for Lab Diagnosis of Infectious Diseases
CDC Investigates U.S. Multi-State Measles Outbreak
New HIVMA Website Offers Resources for HIV Medical Providers and Clinics
CMS Publishes Final Rule for Physician Fee Schedule
Obama Requests Doubling of Funds to Combat Antibiotic Resistance
New Report, The Promise of Next Generation Diagnostics, Targets Policymakers
Progress on the Road to 10 x 20
FDA Moves to Replace Lifetime MSM Blood Donation Ban with One-Year Deferral
Science Speaks: Neglecting ID Anywhere Poses a Threat Everywhere
Members on the Move
New Members
From the President
IDWeek 2015 Sneak Preview of Keynote Speakers
IDSA Foundation Offers Research Awards to Young Investigators
IDSA Journal Club
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add '' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.